Skip to main content
TipRanks
Go Ultimate75% OFF

Ross Mangano Insider Profile

4 Followers

Ross Mangano, Director at ANI Pharmaceuticals, holds 26.91K shares in ANI Pharmaceuticals (Ticker: ANIP). Most recently, Ross Mangano Bought 3,000 shares of ANI Pharmaceuticals on Sep 16, 2014 for an estimated value of $82.47K.

Ross Mangano's Trading History

ANIP
ANI Pharmaceuticals
Sep 16, 2014DirectorInformative Buy82.47K$1.92M
ANIP
Insider Shares: 26.91K (0.23%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 16, 2014Informative Buy$82.47K3,000$27.49+94.40%
May 07, 2014Informative Buy$60.76K2,000$30.38+70.50%
Nov 12, 2013Informative Buy$101.43K9,000$11.27―
Nov 05, 2013Uninformative Buy$0.008,310$0.00―
Aug 22, 2013Informative Buy$74.60K10,000$7.46―

You May Also Like

Ross Mangano insider profile FAQ

What is the percentage of profitable transactions made by Ross Mangano?
The percentage of profitable transactions made by Ross Mangano is 100%.
What is the average return per transaction made by Ross Mangano?
The average return per transaction made by Ross Mangano is 82.40%.
What stocks does Ross Mangano hold?
Ross Mangano holds: ANIP stocks.
What was Ross Mangano’s latest transaction?
Ross Mangano’s latest transaction was an Informative Buy of $82.47K.
What was Ross Mangano's most profitable transaction?
Ross Mangano’s most profitable transaction was an Informative Buy of ANIP stock on September 16, 2014. The return on the trade was 94.40%.
What is Ross Mangano's role in ANI Pharmaceuticals?
Ross Mangano's role in ANI Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.